002007.SZ
华兰生物
SZSE · Healthcare · C 制造业 · CN
CNY 12.84
−2.51%Margins
Gross margin
56.5%
EBITDA margin
33.6%
EBIT margin
25.2%
Net margin
19.1%
FCF margin
15.1%
7.3%
Return on equity
5.7%
Return on assets
9.6%
Return on invested capital
0.30x
Asset turnover
CNY 857.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026